COMMUNICATIONS
d) T. Ohkuma, H. Ikehira, T. Ikariya, R. Noyori, Synlett 1997, 467 ±
468; e) T. Ohkuma, H. Doucet, T. Pham, K. Mikami, T. Korenaga, M.
Terada, R. Noyori, J. Am. Chem. Soc. 1998, 120, 1086 ± 1087.
[2] T. A. Stephenson, G. Wilkinson, J. Inorg. Nucl. Chem. 1966, 28, 945 ±
956.
[3] a) M. Kitamura, M. Tokunaga, T. Ohkuma, R. Noyori, Tetrahedron
Lett. 1991, 32, 4163 ± 4166. b) Org. Synth. 1993, 71, 1 ± 13.
[4] a) P. Mangeney, T. Tejero, A. Alexakis, F. Grosjean, J. Normant,
Synthesis 1988, 255 ± 257; b) S. Pikul, E. J. Corey, Org. Synth. 1993, 71,
22 ± 29; c) S.-J. Wey, K. J. OꢁConnor, C. J. Burrows, Tetrahedron Lett.
1993, 34, 1905 ± 1908.
[5] a) T. Ikariya, Y. Ishii, H. Kawano, T. Arai, M. Saburi, S. Yoshikawa, S.
Akutagawa, J. Chem. Soc. Chem. Commun. 1985, 922 ± 924; b) S. A.
King, L. DiMichele in Catalysis of Organic Reactions (Eds.: M. G.
Scaros, M. L. Prunier), Dekker, New York, 1995, pp. 157 ± 166; c) T.
Ohta, Y. Tonomura, K. Nozaki, H. Takaya, K. Mashima, Organo-
metallics, 1996, 15, 1521 ± 1523.
(Eds.: P. M. Müller, D. Lamparsky), Blackie Academic & Professio-
nal, London, 1991, Chapter 4.
[17] T. Hayashi, Y. Matsumoto, Y. Ito, J. Am. Chem. Soc. 1989, 111, 3426 ±
3428.
[18] H. C. Brown, B. T. Cho, W. S. Park, J. Org. Chem. 1988, 53, 1231 ±
1238.
[19] S. M. Resnick, D. S. Torok, D. T. Gibson, J. Org. Chem. 1995, 60,
3546 ± 3549.
[20] T. Hayashi, Y. Matsumoto, Y. Ito, Tetrahedron: Asymmetry 1991, 2,
601 ± 612.
[21] H. L. Holland, E. J. Bergen, P. C. Chenchaiah, S. H. Khan, B. Munoz,
R. W. Ninniss, D. Richards, Can. J. Chem. 1987, 65, 502 ± 507.
[22] M. Ito, Y. Kobayashi, (Jpn. Kokai Tokkyo Koho), JP 03191796, 1991
(Chem. Abstr. 1992, 116, 104514a).
[23] P. D. Theisen, C. H. Heathcock, J. Org. Chem. 1988, 53, 2374 ± 2378.
[24] T. Shono, N. Kise, E. Shirakawa, H. Matsumoto, E. Okazaki, J. Org.
Chem. 1991, 56, 3063 ± 3067.
[6] a) K. Mashima, K. Kusano, T. Ohta, R. Noyori, H. Takaya, J. Chem.
Soc. Chem. Commun. 1989, 1208 ± 1210; b) K. Mashima, K. Kusano, N.
Sato, Y. Matsumura, K. Nozaki, H. Kumobayashi, N. Sayo, Y. Hori, T.
Ishizaki, S. Akutagawa, H. Takaya, J. Org. Chem. 1994, 59, 3064 ±
3076.
[25] B. Weber, D. Seebach, Tetrahedron 1994, 50, 7473 ± 7484.
[26] a) M. P. Balfe, G. H. Beaven, J. Kenyon, J. Chem. Soc. 1950, 1857 ±
1860; b) I. Ojima, T. Kogure, M. Kumagai, S. Horiuchi, T. Sato, J.
Organomet. Chem. 1976, 122, 83 ± 97.
Ã
[7] J. P. Genet, C. Pinel, V. Ratovelomanana-Vidal, S. Mallart, X. Pfister,
Ä
L. Bischoff, M. C. Cano de Andrade, S. Darses, C. Galopin, J. A.
Laffitte, Tetrahedron: Asymmetry 1994, 5, 675 ± 690.
[8] S. Cenini, F. Porta, M. Pizzotti, J. Mol. Catal. 1982, 15, 297 ± 308.
[9] H. Takaya, K. Mashima, K. Koyano, M. Yagi, H. Kumobayashi,
T. Taketomi, S. Akutagawa, R. Noyori, J. Org. Chem. 1986, 51, 629 ±
635.
Parallel Synthesis of Sialyl Lewis X Mimetics on
a Solid Phase: Access to a Library of
Fucopeptides**
[10] X-ray crystallographic analysis was performed with a Rigaku AFC
diffractometer (graphite monochromator, MoKa radiation). The
structures were solved with PATTY and DIRDIF94. (R),(R,R)-2d:
C62H56Cl2N2P2Ru, Mr 1063.06, orange crystal, 0.1 Â 0.1 Â 0.1 mm,
monoclinic, space group C2 (no. 5), a 24.50(1), b 20.533(9), c
Thomas F. J. Lampe, Gabriele Weitz-Schmidt, and
Chi-Huey Wong*
24.80(1)
b 119.20(3)8, V 10908(10) 3,
Z 8,
1calcd
1,
1.294 gcm 3, m(MoKa) 4.84 m
T 296 K. 9880 reflections were
independent and unique, and 6220 with I > 3.00s(I) (2qmax 508) were
used for the solution of the structure. All hydrogen atoms were
calculated from ideal geometries, fixed, and included in the calcu-
lation of the structural factor. R 0.034, Rw 0.034. (R),(S,S)-2e:
C62H56Cl2N2P2Ru, Mr 1063.06, orange crystal, 0.1 Â 0.1 Â 0.2 mm,
monoclinic, space group C2 (no. 5), a 24.74(2), b 20.49(1), c
In response to injury or inflammation the damaged tissue
releases cytokines, which trigger the expression of P-selectin
followed by E-selectin on the endothelium. The initial
recognition of the tetrasaccharide sialyl Lewis X (sLex) of
the terminal unit of surface glycoconjugates by the selectins
leads to leukocyte ªrollingº followed by protein ± protein
interactions (integrins CD11/18, ICAM-1 ligand) and extrav-
asation of leukocytes into the endothelium.[1] Thus, blocking
the sLex/selectin interactions at an early stage of the
inflammatory cascade, especially the P-selectin/ligand inter-
actions, has been considered to be an effective way of treating
acute and perhaps chronic inflammatory diseases.[2]
Although sLex is being clinically evaluated for the treat-
ment of reperfusion injury, it must be administered by
injection at high doses, as it binds the selectins weakly and
is orally inactive and unstable in the blood. However, the
structure of sLex has served as a useful guide for designing
simpler and better low molecular weight compounds as
25.04(1)
b 120.79(4)8, V 10908(11) 3,
Z 8,
1calcd
1,
1.294 gcm 3, m(MoKa) 4.84 m T 296 K. 12862 reflections were
independent and unique, and 7807 with I > 3.00s(I) (2qmax 558) were
used for the solution of the structure. All hydrogen atoms were
calculated from ideal geometries, fixed, and included in the calcu-
lation of the structural factor. R 0.034, Rw 0.033. Crystallographic
data (excluding structure factors) for the structures reported in this
paper have been deposited with the Cambridge Crystallographic Data
Center as supplementary publication no. CCDC-101399. Copies of the
data can be obtained free of charge on application to CCDC, 12 Union
Road, Cambridge CB21EZ, UK (fax: (44)1223-336-033; e-mail:
deposit@ccdc.cam.ac.uk).
[11] W. A. Herrmann, B. Cornils, Angew. Chem. 1997, 109, 1074 ± 1095;
Angew. Chem. Int. Ed. Engl. 1997, 36, 1048 ± 1067.
[12] The turnover number (TON) is the number of moles of product per
mole of catalyst. The turnover frequency (TOF) is the TON per hour
or second.
[13] Reaction with the diastereomeric isomer (R),(S,S)-2e, either pre-
formed or formed in situ, gave the S alcohol in 15 Æ 2%.
[*] Prof. Dr. C.-H. Wong, Dr. T. F. J. Lampe
The Scripps Research Institute
[14] Various alkaline bases, such as KOH, (CH3)2CHOK, (CH3)2CHONa,
(CH3)3COK, and K2CO3 can be used as cocatalysts. For reactions with
a high S/C, acidic impurities should be carefully removed from
substrates and solvents.
Department of Chemistry
10550 North Torrey Pines Road, La Jolla, CA 92037 (USA)
Fax : ( 1)619-784-2409
Dr. G. Weitz-Schmidt
Novartis Pharma AG
Preclinical Research
[15] Reaction of [RuCl2{(S)-TolBINAP}(dmf)n] and (S,S)-DPEN in
DMF at 508C (method B) gave a mixture of (S),(S,S)-2d and its cis
isomer (31P NMR, d 50.2 (d, J 38.0 Hz), 57.0 (d, J 38.0 Hz)).
Hydrogenation of 5g with the cis isomer showed comparable
reactivity to (S),(S,S)-2d, to give (R)-6 g with 97% ee.
CH-4002 Basel (Switzerland)
[**] We gratefully acknowledge financial support of our work by Novartis
Pharma AG and the NSF and the award of a DFG-Stipendium to
T.F.J.L. by the Deutsche Forschungsgemeinschaft.
[16] a) K. Mori, P. Puapoomchareon, Liebigs Ann. Chem. 1991, 1053 ±
1056; b) R. Croteau, F. Karp In Perfumes: Art, Science and Technology
Angew. Chem. Int. Ed. 1998, 37, No. 12
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 1998
1433-7851/98/3712-1707 $ 17.50+.50/0
1707